[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@AceStocks88 Tanner H.

Tanner H. posts on X about $lyra, runner, market cap, 15m the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

X Week XXXXX +128%
X Month XXXXX +1,281%
X Months XXXXXX +238%
X Year XXXXXX +60%

Mentions: XX #

X Week XX +33%
X Month XX +525%
X Months XX +210%
X Year XX +144%

Followers: XXX #

X Week XXX +2.10%
X Month XXX +5.90%
X Months XXX +19%
X Year XXX -XXXX%

CreatorRank: XXXXXXXXX #

Social Influence #

Social category influence cryptocurrencies XXXXX% finance XXXX%

Social topic influence $lyra #1, runner #1121, market cap #1457, 15m #102, os 7.32%, 1m 2.44%, $qnrx 2.44%, rhino #46

Top accounts mentioned or mentioned by @stockplaymaker1 @uavcorp @curiosg1985 @maceosremy @northshoretrade @mmatters22596 @moonmarket @johnzidar @cofffree @sarwanjohn @ordinaryinvestr @jacksurvived @jacobsjones92 @kennyfharris @spartatrades @superduperinvst @learningdatruth @ttstocks @dehixtrades @topstockalerts1

Top assets mentioned LYRA (LYRA)

Top Social Posts #

Top posts by engagements in the last XX hours

"@stockplaymaker1 $LYRA low float (1.12M) low OS (1.64M) biotech w/ Phase X asset for rhino sinusitis. Cash runway into 2026. Former runner to near XX. Market cap 15M"
X Link @AceStocks88 2025-10-11T04:33Z XXX followers, XXX engagements

"@coff_free @SarwanJohn I like $LYRA as well. It has an active Phase X asset; cash runway into 2026 + just 1.6ish Million OS. Float just over 1M"
X Link @AceStocks88 2025-10-10T15:13Z XXX followers, XXX engagements

"@MMatters22596 Agree this is a good time for biotech with rate cuts (hopefully) & better access to financing. More consolidation and M & A activity in space too. Like late stage + commercial in particular. One example is $LYRA w/ Ph3 asset and a successful trial already. Many though"
X Link @AceStocks88 2025-10-12T23:00Z XXX followers, XXX engagements

"@SuperDuperInvst If $LYRA gets partnership news for financing Ph3 trial or other big news it might. 1.6M OS Biotech"
X Link @AceStocks88 2025-10-15T20:10Z XXX followers, XXX engagements

"@MMatters22596 $LYRA"
X Link @AceStocks88 2025-10-12T03:49Z XXX followers, XXX engagements

"@MoonMarket_ $LYRA low float (1.12M) low OS (1.64M) biotech w/ Phase X asset for rhino sinusitis. Cash runway into 2026. Former runner to near XX. Market cap 15M"
X Link @AceStocks88 2025-10-11T16:44Z XXX followers, XXX engagements

"@TT_stocks_ I like $LYRA for a watch anyway. Has an active Phase X asset and previously ran from X to XX. FDA wants one more trial but still relatively cheap here. 1.6M OS"
X Link @AceStocks88 2025-10-15T20:07Z XXX followers, XXX engagements

"@stockplaymaker1 $LYRA and $QNRX"
X Link @AceStocks88 2025-10-12T03:48Z XXX followers, XXX engagements

"@MoonMarket_ I believe $LYRA is presenting positive Ph3 data as well on Monday 10/13"
X Link @AceStocks88 2025-10-11T16:44Z XXX followers, XXX engagements

"@Dehix_Trades Not sure about next Friday but I like $LYRA low float (1.12M) low OS (1.64M) biotech w/ Phase X asset for rhino sinusitis. Cash runway into 2026. Former runner to near XX. Market cap 15M"
X Link @AceStocks88 2025-10-10T21:07Z XXX followers, XXX engagements